Stock Chart

BFRI

$0.91 -1.93%
Score: 43.3 HOLD
Pro
Screener
Vol: 0.38x (vs SPY: 0.9x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 11, 2026
Symmetrical Triangle Bullish scenario quality 61/100
Measured-move target $0.98 (+7.5%) · apex ~17 bars ahead
Historically breaks up 54% overall; 71% up when formed in a downtrend (n=131)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BFRI - Biofrontera Inc. Common Stock

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Key Statistics

Market Cap $13M

More BFRI Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This BFRI stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BFRI's price movements with trendlines, gamma walls, and key support/resistance levels.